Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is completed in Japan. It focuses on ADHD.
In FukuokaThis study is completed in the United States. It is testing Multiple Doses of ASP8062 With a Single Dose of Morphine for Addiction.
In Overland ParkThis study is completed in the United States. It is testing Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of ASP6981 for schizophrenia.
Multiple locations, including GlendaleThis study is completed in Rwanda. It is testing treatment of Schizophrenia With Paliperidone Palmitate for schizophrenia.
Multiple locations, including ButareThis study is completed in the United States, in the United Kingdom, and in Ireland. It is testing use of Methylone for PTSD.
Multiple locations, including Denver
This study is completed in the United States. It focuses on Suicide prevention.
Multiple locations, including BirminghamThis study is completed in the United States. It focuses on Addiction.
Multiple locations, including CharlotteThis study is completed in the United States, in Brazil, and in Mexico. It focuses on schizophrenia.
Multiple locations, including Little RockThis study is completed. It focuses on schizophrenia.
Location not clearly listedThis study is completed in China. It is testing ziprasidone and Risperidone for schizophrenia.
Multiple locations, including BeijingThis study is completed in the United States. It focuses on depression.
Multiple locations, including PhoenixThis summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including ChoongjuHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.